Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Korean J Radiol. 2021 Jan;22(1):23-40. doi: 10.3348/kjr.2019.0862. Epub 2020 Aug 28.
In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.
在胰腺癌中，影像学在监测、诊断、可切除性评估和治疗反应评估中发挥着重要作用。已经尝试使用内镜超声（EUS）或磁共振成像（MRI）对高危人群进行胰腺癌监测。影像学诊断和可切除性评估是影响治疗决策的最重要因素，其中计算机断层扫描（CT）是首选方式。EUS、MRI 和正电子发射断层扫描（PET）在 CT 的基础上发挥互补作用。治疗反应评估具有越来越重要的临床意义，尤其是在接受新辅助治疗的患者中。本综述旨在全面回顾影像学在当前胰腺癌治疗策略中的作用，包括监测、诊断、可切除性评估和治疗反应评估以及预后预测。
